ZICOM GROUP LIMITED — Capital/Financing Update 2012

Jun 26, 2012

Zicom Gr Limited ABN 62 009 816 871 oup

==> picture [64 x 16] intentionally omitted <==

==> picture [64 x 16] intentionally omitted <==

==> picture [64 x 16] intentionally omitted <==

38 Goodman Place, Murarrie, Queensland 4172 • Tel: (07) 3908 6088 • Fax: (07) 3390 6898

27 June 2012

Market Announcement Office Australian Securities Exchange Level 6, 20 Bridge Street SYDNEY NSW 2000

Dear Sir,

UPDATE ON AN ASSOCIATE COMPANY BIOBOT SURGICAL PTE LTD

Further to our announcements on 10 February 2012 and 30 April 2012, the Group is pleased to announce that the legal disputes between its associate company, BioBot Surgical Pte Ltd, (“Biobot”) and Biobot’s Founder-shareholder have been amicably resolved in a High Court Mediation.

As an outcome of the Mediation, all parties agree to withdraw their respective claims and bear their own costs and that our wholly owned intermediate holding company, Zicom Holdings Pte Ltd shall acquire the entire 33.33% shareholdings in Biobot owned by the Founder-shareholder for a nominal consideration. This will result in BioBot becoming a Group’s subsidiary.

The Group is fully satisfied with the outcome and believes the settlement will enable all parties to move on in their respective endeavours. The Group’s confidence in accelerating its progress to develop the product to full commercialisation has strengthened and it is committed to support the technology which remains in the forefront of its class. The Group has recently injected 50% of S$812,219.00 as convertible loans to BioBot with the balance to be injected in September 2012. These investments are fully funded from internal resources.

BioBot aims to have its technology and product commercialised in the second quarter of 2013.

Yours faithfully ZICOM GROUP LIMITED

==> picture [36 x 50] intentionally omitted <==

-------------------------------G L Sim Chairman.

1 New Business